Novira Therapeutics

Novira is an antiviral drug discovery company launched in 2009 that is focused on the discovery of novel, first-in-class therapeutics for the treatment of HBV and HIV, two global diseases in need of better therapies. The company is founded and led by Ali H. Munawar alongside seasoned pharma execs. The company has identified and is further optimizing a promising pipeline of drugs that disrupt virus capsid assembly of HIV and HBV using an efficient and innovative model of biomedical research.